NCT07297056Completed
Mindfulness Psychoeducation for Bipolar Disorder
The Effect of Mindfulness-Based Psychoeducation Programme on Mindfulness, Self-Compassion and Forgiveness Tendencies of Patients With Bipolar Disorder: A Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 31 Dec 2025
Brief summary (registry, in English)
This randomized controlled experimental study investigates the effectiveness of a mindfulness-based psychoeducation program on mindfulness, self-compassion, and forgiveness among individuals diagnosed with bipolar disorder. Bipolar disorder is a chronic psychiatric condition characterized by fluctuations in mood, energy, and functional capacity, often accompanied by emotional dysregulation, impaired insight, and challenges in interpersonal relationships. Psychosocial interventions that cultivate emotional awareness and adaptive coping may support recovery and enhance long-term functioning. In this study, 40 clinically stable patients with bipolar disorder were randomly assigned to either an experimental group (n=20) or a control group (n=20). The experimental group received a structured mindfulness-based psychoeducation program, while the control group received no additional intervention beyond usual care. Participants completed pre- and post-intervention assessments using a personal information form, the Mindfulness Scale, the Self-Compassion Scale-Short Form, and the Heartland Forgiveness Scale. Findings demonstrated that individuals who participated in the mindfulness-based psychoeducation program showed significantly greater improvements in mindfulness, self-compassion, and forgiveness compared with the control group. These results suggest that integrating mindfulness-based psychoeducation into routine care may promote emotional resilience, enhance illness insight, support symptom management, and strengthen interpersonal functioning in individuals with bipolar disorder.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 9 Dec 2025
- Start date
- 3 Mar 2025
- Primary completion date
- 2 May 2025
- Lead sponsor
- Ömer USLU
- Diseases
- Bipolar disorder
- NCT number
- NCT07297056
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 3 Mar 2025 to the primary completion date, 2 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Comorbid intellectual disability, neurological disorder, or severe cognitive impairment
- Severe visual or hearing impairment preventing participation
- Any condition judged by the clinician to contraindicate participation in group sessions
Other
- Presence of acute psychotic symptoms requiring immediate hospitalization
- Substance or alcohol dependence within the last 6 months
- Participation in any mindfulness-based or psychoeducational program within the last year
Who the study is looking for
- Diagnosis of bipolar disorder according to DSM-5 criteria
- Age between 18 and 65 years
- Clinically stable for at least the past 3 months
- Able to communicate, read, and understand Turkish
- Receiving outpatient psychiatric follow-up
- Willingness to participate and provide informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Söke Fehime Faik Kocagöz Hospital Coordinator of this site? Confirm its status | Aydin | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.